Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.50
Bid: 42.00
Ask: 43.00
Change: 2.10 (5.20%)
Spread: 1.00 (2.381%)
Open: 42.75
High: 42.75
Low: 41.00
Prev. Close: 40.40
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

23 Dec 2013 07:00

RNS Number : 1772W
Avacta Group PLC
23 December 2013
 



 

 

 

Avacta Group plc

("Avacta" or the "Group")

 

Craig Slater joins the Board of Avacta Group plc as Chief Operating Officer

 

Avacta Group plc, the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, is pleased to announce that Craig Slater has joined the Board as Chief Operating Officer with immediate effect.

 

Mr Slater has more than 25 years experience of commercial, operational and group management roles in specialist engineering, construction, software and marketing groups. More specifically this experience includes the supply of specialist equipment to Life Science clients, B2B service provision and the implementation of growth plans in SME businesses. Mr Slater has been working with Avacta since June 2012, primarily in a commercial and operational capacity within Avacta Analytical and latterly within Avacta Animal Health.

 

Commenting on the appointment, Alastair Smith, Chief Executive of Avacta said: "The Board is delighted that Craig is joining the Group as Chief Operating Officer. We have already benefited greatly from his experience since he joined us in 2012 and his operational and strategic input will be invaluable in the future."

 

Mr Slater, aged 50, is a director/partner or has been a director/partner of the following companies/partnerships during the previous five years:

 

Current Directorships

Veracito Limited

QPC Holdings Limited

Adapt Formwork Holdings Limited

Adapt Formwork Limited

Gateway 3D Limited

Sitedesk Limited

 

Previous Directorships (in last 5 years)

Eleco Public Limited Company

Bell & Webster Concrete Limited

Milbury Systems Limited

Eleco (Pp) Limited

Eleco (Dcs) Limited

Eleco (Spp) Limited

Eleco (Gns) Limited

Eleco (Sd) Limited

CORGI Group Limited

Corgi Gas Registration Limited

Corgi Services Limited

Altitude Group Plc

Adproducts.com Limited

Advertising Gifts Limited

Advertising Gifts.net Limited

Boxcam Limited

Brand Logistics Limited

Business Gifts Limited

Corporate Gifts Limited

Corporate Solutions (UK) Limited

Distinctive Ideas Limited

Dowlis Corporate Solutions (UK) Limited

Promoserve Business Systems Limited

Promotional Gifts Limited

Promotional Items Limited

Promotional Merchandise Limited

Promotional Store Limited

Ross Promotional Products Limited

Silent Kite Limited

The Advertising Products Group Limited

The Bentley Collection Limited

Touchpaper Communications Limited

Trade Only Limited

 

Mr Slater does not hold any ordinary shares, or options over ordinary shares, in the Company.

 

Save for the information disclosed above there is no other information to be disclosed on Mr Slater under Schedule 2(g) of the AIM Rules.

 

- Ends -

 

Enquiries:

 

Avacta Group plc

www.avacta.com

Alastair Smith, Chief Executive Officer

Tel: +44 (0) 844 414 0452

Tim Sykes, Chief Financial Officer

 

 

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

 

James Black (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com

Mike Wort

Mob: +44 (0)7900 608 002

Lianne Cawthorne

Mob: +44 (0)7584 391 303

 

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

 

Avacta Analytical

www.avactaanalytical.com

 

High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.

Avacta Animal Health

www.avactaanimalhealth.com

 

Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFEWFFFFDSELE
Date   Source Headline
10th Oct 20177:00 amRNSAvacta to Present at Major US Conference
9th Oct 20174:02 pmRNSDirector Dealing and Issue of Equity
5th Oct 20177:00 amRNSResearch collaboration with FIT Biotech Oy
4th Oct 20177:00 amRNSPreliminary Results
2nd Oct 20177:00 amRNSAvacta establishes US business development team
7th Sep 20177:00 amRNSNotice of Results
21st Aug 201712:00 pmRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSTrading Update
31st Jul 201712:00 pmRNSIssue of Equity
28th Jul 20171:15 pmRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSDirector Dealing and Issue of Equity
4th Jul 20177:00 amRNSManchester ShareSoc Growth Company Seminar
5th Jun 20177:00 amRNSShareSoc Growth Company Seminar
1st Jun 20178:56 amRNSIssue of Equity
22nd May 20177:00 amRNS2 Biotech's Licence Affimers for Research Use
10th May 20177:00 amRNSKey Affimer Patent To Be Granted in China
8th May 20171:21 pmRNSHardman Research: De-risking Moderna's partnership
5th May 20177:00 amRNSPresenting at the Hardman Private Investor Forum
2nd May 20177:00 amRNSAvacta to Present at BioTrinity 2017
24th Apr 20177:00 amRNSDiagnostics firm take rights to several Affimers
19th Apr 20177:00 amRNSAvacta to Present at the Shares Spotlight Evening
12th Apr 20177:15 amRNSHardman Research: Another important box ticked
6th Apr 20172:23 pmRNSHolding(s) in Company
6th Apr 20172:23 pmRNSHolding(s) in Company
6th Apr 201710:22 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSInterim Results for the Period Ended 31 Jan 2017
3rd Apr 20177:00 amRNSResults of Immunogenicity Study with Human Samples
31st Mar 20179:31 amRNSAvacta Presents at Investor Evening Hosted by TPI
31st Mar 20177:00 amRNSLondon Growth and Innovation Forum Presentation
22nd Mar 20179:00 amRNSAvacta to present at the UK Investor Show
21st Mar 20177:15 amRNSHardman Research: Low response would be positive!
30th Jan 20177:00 amRNSDirector/PDMR Shareholding
20th Jan 201711:35 amRNSResult of Annual General Meeting
20th Jan 20177:00 amRNSTrading Update
11th Jan 20177:00 amRNSPresenting at London Growth and Innovation Forum
5th Jan 20177:00 amRNSDirector Dealing and Issue of Equity
20th Dec 20167:00 amRNSDirector/PDMR Shareholding
16th Dec 20165:14 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSNotice of AGM, Accounts and Directorate Change
23rd Nov 20167:00 amRNSTechnical Update: Affinity Separation
7th Nov 20167:00 amRNSCancer Expert joins Scientific Advisory Board
2nd Nov 20167:00 amRNSCAR-T Cell Therapy Research Collaboration in US
1st Nov 20167:00 amRNSResults from first Affimer pre-clinical studies
21st Oct 201611:39 amRNSDirector's Dealing
17th Oct 20161:00 pmRNSHardman Research: Great strides to strategic goals
17th Oct 20167:00 amRNSPrelim Results for the Year Ended 31 July 2016
4th Oct 20163:28 pmRNSIssue of Equity
26th Sep 201611:21 amRNSNotice of Results
22nd Sep 20167:00 amRNSPositive results from first preclinical studies
12th Sep 20167:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.